Literature DB >> 26059880

Novel gain of function mutation in the SLC40A1 gene associated with hereditary haemochromatosis type 4.

S-R Chen1,2, L-Q Yang3, Y-T Chong1,2, Y-S Jie1,2, Y-K Wu1,2, J Yang3, G-L Lin1,2, X-H Li1,2.   

Abstract

Here we report the case of a 69-year-old Chinese Han woman who presented with liver cirrhosis, diabetes mellitus, skin hyperpigmentation, hyperferritinaemia and high transferrin saturation. Subsequent genetic analyses identified a novel heterozygous mutation (p.Cys326Phe) in the SLC40A1 gene. This is the first report regarding a SLC40A1 mutation in the Chinese Han population and provides novel clinical evidence for the importance of p.Cys326 in SLC40A1 gene function.
© 2015 Royal Australasian College of Physicians.

Entities:  

Keywords:  Chinese; SLC40A1; ferroportin disease; hereditary haemochromatosis type 4; mutation

Mesh:

Substances:

Year:  2015        PMID: 26059880     DOI: 10.1111/imj.12764

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  7 in total

1.  Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress.

Authors:  De-Liang Zhang; Manik C Ghosh; Hayden Ollivierre; Yan Li; Tracey A Rouault
Journal:  Blood       Date:  2018-09-13       Impact factor: 22.113

2.  Exploring evidence of positive selection signatures in cattle breeds selected for different traits.

Authors:  Mengistie Taye; Wonseok Lee; Soomin Jeon; Joon Yoon; Tadelle Dessie; Olivier Hanotte; Okeyo Ally Mwai; Stephen Kemp; Seoae Cho; Sung Jong Oh; Hak-Kyo Lee; Heebal Kim
Journal:  Mamm Genome       Date:  2017-09-13       Impact factor: 2.957

Review 3.  Type 4B hereditary hemochromatosis associated with a novel mutation in the SLC40A1 gene: A case report and a review of the literature.

Authors:  Wei Zhang; Tingxia Lv; Jian Huang; Xiaojuan Ou
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

4.  Iron chelators reverse organ damage in type 4B hereditary hemochromatosis: Case reports.

Authors:  Ling-Yan Wu; Zhen-Ya Song; Qing-Hai Li; Li-Jun Mou; Ying-Ying Yu; Si-Si Shen; Xiao-Xiao Song
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

5.  The novel SLC40A1 (T419I) variant results in a loss-of-function phenotype and may provide insights into the mechanism of large granular lymphocytic leukemia and pure red cell aplasia.

Authors:  Hongfei Wu; Xiang Ren; Meili Ge; Peiyuan Dong; Shichong Wang; Huiming Yi; Xingxin Li; Jiali Huo; Xuan Zheng; Mengying Gao; Jinbo Huang; Jing Zhang; Min Wang; Peng Jin; Neng Nie; Yingqi Shao; Yizhou Zheng
Journal:  Blood Sci       Date:  2021-12-06

Review 6.  Ferroportin disease: pathogenesis, diagnosis and treatment.

Authors:  Antonello Pietrangelo
Journal:  Haematologica       Date:  2017-11-03       Impact factor: 9.941

Review 7.  Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.

Authors:  L Tom Vlasveld; Roel Janssen; Edouard Bardou-Jacquet; Hanka Venselaar; Houda Hamdi-Roze; Hal Drakesmith; Dorine W Swinkels
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.